Skip to main content

Market Overview

NuVasive Announces Acquisition Of Ellipse Technologies, Notes 'Potential To Become The Standard Of Care'


NuVasive, Inc. (NASDAQ: NUVA), a global medical device company in the spine market, announced on Tuesday it has agreed to acquire Ellipse Technologies for $380 million upfront and a potential $30 million milestone payment.

Ellipse Technologies is a privately held medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity.

NuVasive said it expects the acquisition to accelerate its revenue growth target toward the high-single digit range and to be "slightly accretive" to its non-GAAP diluted earnings per share within the first 12 months of the acquisition and "significantly accretive" moving forward.

NuVasive's CEO Gregory Lucier said Ellipse's "revolutionary" technology "has the potential to become the standard of care for spine and orthopedic patients."

Shares of NuVasive were trading higher by more than 1 percent at $54.07 shortly after Wednesday's opening bell.


Related Articles (NUVA)

View Comments and Join the Discussion!

Posted-In: Ellipse TechnologiesBiotech Long Ideas M&A News Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at